A. Goodwin

发表

Characterization of an Acidic-pH-Inducible Stress Protein (hsp70), a Putative Sulfatide Binding Adhesin, fromHelicobacter pylori

C. Lingwood, M. Huesca, A. Goodwin, 1998, Infection and Immunity.

Metabolic activities of metronidazole-sensitive and -resistant strains of Helicobacter pylori: repression of pyruvate oxidoreductase and expression of isocitrate lyase activity correlate with resistance

Zanten, P. Hoffman, S. Veldhuyzen van Zanten, 1996, Journal of bacteriology.

Metronidazole resistance in Helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen‐insensitive NADPH nitroreductase

D. Berg, G. Sisson, P. Hoffman, 1998, Molecular microbiology.

Sequential Inactivation of rdxA (HP0954) and frxA (HP0642) Nitroreductase Genes Causes Moderate and High-Level Metronidazole Resistance in Helicobacter pylori

B. C. Wong, D. Berg, G. Nair, 2000, Journal of bacteriology.

Enzymes Associated with Reductive Activation and Action of Nitazoxanide, Nitrofurans, and Metronidazole in Helicobacter pylori

D. Berg, A. Mukhopadhyay, G. Sisson, 2002, Antimicrobial Agents and Chemotherapy.

Phosphorylation and activation of p42 and p44 mitogen-activated protein kinase are required for the P2 purinoceptor stimulation of endothelial prostacyclin production.

N. Wilkie, A. Goodwin, A. Goodwin, 1996, The Biochemical journal.

Characterization of the NAD(P)H oxidase and metronidazole reductase activities of the RdxA nitroreductase of Helicobacter pylori

P. Hoffman, A. Goodwin, I. Olekhnovich, 2009, The FEBS journal.

Metronidazole Activation Is Mutagenic and Causes DNA Fragmentation in Helicobacter pylori and inEscherichia coli Containing a Cloned H. pylori rdxA+ (Nitroreductase) Gene

D. Berg, G. Sisson, P. Hoffman, 2000, Journal of bacteriology.

Antimicrobial Susceptibility Testing Protocols

R. Schwalbe, L. Steele-Moore, A. Goodwin, 2007 .

Insertion of Mini-IS605 and Deletion of Adjacent Sequences in the Nitroreductase (rdxA) Gene Cause Metronidazole Resistance in Helicobacter pyloriNCTC11637

D. Berg, C. Vandenbroucke-Grauls, D. van Westerloo, 1999, Antimicrobial Agents and Chemotherapy.

Macro- and Microdilution Methods of Antimicrobial Susceptibility Testing

R. Schwalbe, L. Steele-Moore, A. Goodwin, 2007 .

US Food and Drug Administration (FDA): Benefit-Risk Considerations for Cefiderocol (Fetroja®).

E. Weinstein, D. Iarikov, D. Rubin, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.